WASHINGTON — “The guy who made a killing” — that’s how a patient advocacy group fighting high drug prices refers to former Celgene CEO Bob Hugin in a television ad set to air Friday.
Hugin, who is challenging Sen. Bob Menendez (D) for his seat in New Jersey, has been criticized for price increases that occurred at Celgene under his leadership. Patients for Affordable Drugs, an advocacy group of rising prominence here, said in a statement it spent $1.5 million to air the ad for several weeks across New Jersey.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
